← All companies

Astraea

Active

Agents that accelerate clinical trials.

P26·Spring 2026·B2B·San Francisco, CA, USA·Team of 2·Founded 2026

About

Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.

Founders

  • Sanmay Sarada· Founder

    prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford

  • Joshua Wang· Founder

    Previous undergraduate at Stanford studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.

Product launches · 1 launch

Change history · none recorded

No changes recorded yet. Subsequent syncs will populate this timeline as fields drift.